JohnStuartYordyMDPhD

PubMed

• 3 citations
  Evaluation of the Response of HNSCC Cell Lines to γ-Rays andC Ions: Can Radioresistant Tumors Be Identified and Selected forC Ion Radiotherapy?
  Lianghao Ding, Brock J Sishc, Elizabeth Polsdofer, John S Yordy, Angelica Facoetti, Mario Ciocca, Debabrata Saha, Arnold Pompos, Anthony J Davis, Michael D Story> ;Frontiers in Oncology. 2022 Jan 1
• 32 citations
  miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer
  Dat T. Vo, Narasimha Kumar Karanam, Lianghao Ding, Debabrata Saha, J Yordy, Uma Giri, John V. Heymach, Michael D. Story> ;Neoplasia. 2019 Sep 1
• 3 citations
  Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer
  Chuxiong Ding, Stephen G. Chun, Baran D. Sumer, Lucien A. Nedzi, Ramzi Abdulrahman, John S. Yordy, Pam Lee, Brian Hrycushko, Timothy D. Solberg, Chul Ahn, Robert Timme...> ;Medical Dosimetry. 2017 Feb 2
• 6 citations
  A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
  Stephen G. Chun, Randall S. Hughes, Baran D. Sumer, Larry L. Myers, John M. Truelson, Saad A. Khan, Tsung Wei Ma, Yang Xie, John S. Yordy, Susan Cooley, Jean Wu, Hak C...> ;Cancer Investigation. 2017 Jan 2
• 39 citations
  NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
  Long Shan Li, Srilakshmi Reddy, Zhen Hua Lin, Shuangping Liu, Hyunsil Park, Stephen G. Chun, William G. Bornmann, Joel Thibodeaux, Jingsheng Yan, Gaurab Chakrabarti, X...> ;Molecular Cancer Therapeutics. 2016 Jan 1
• 1 citations
  Driver missense mutation identification using feature selection and model fusion
  Ahmed T. Soliman, Tao Meng, Shu-Ching Chen, S. Sitharama Iyengar, Puneeth Iyengar, J Yordy, Mei-Ling Shyu> ;Journal of Computational Biology. 2015 Nov 30
• 116 citations
  Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer
  David M. Neskey, Abdullah A. Osman, Thomas J. Ow, Panagiotis Katsonis, Thomas O. McDonald, Stephanie C. Hicks, Teng-Kuei Hsu, Curtis R. Pickering, Alexandra M. Ward, A...> ;Cancer Research. 2015 Apr 1
• 18 citations
  Automated landmark-guided deformable image registration.
  V. Kearney, Susie Chen, Xuejun Gu, Tsuicheng Chiu, H Liu, L Jiang, Jing Wang, J Yordy, Lucien A. Nedzi, Weihua Mao> ;Physics in Medicine and Biology. 2015 Jan 7
• 10 citations
  Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.
  Stephen G. Chun, Hyunsil Park, Raj K. Pandita, Nobuo Horikoshi, Tej K. Pandita, David L. Schwartz, John S. Yordy> ;American Journal of Cancer Research. 2015 Jan 1
• 21 citations
  Commissioning and initial stereotactic ablative radiotherapy experience with Vero
  Timothy D. Solberg, Paul M. Medin, Ezequiel Ramirez, Chuxiong Ding, Ryan D. Foster, J Yordy> ;Journal of Applied Clinical Medical Physics. 2014 Mar 6
• 30 citations
  Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
  Lifen Cao, Long Shan Li, Christopher Spruell, Ling Xiao, Gaurab Chakrabarti, Erik A. Bey, Kathryn E. Reinicke, Melissa C. Srougi, Zachary R. Moore, Ying Dong, Peggy Vo...> ;Antioxidants & Redox Signaling. 2014 Jul 10
• 14 citations
  A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors).
  Stephen G. Chun, Lucien A. Nedzi, Kevin S. Choe, Ramzi Abdulrahman, Susie A. Chen, J Yordy, Robert Timmerman, Joe Walter Kutz, Brandon Isaacson> ;Stereotactic and Functional Neurosurgery. 2014 Jan 1
• 92 citations
  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.
  Arun Gupta, Clayton R. Hunt, Sharmistha Chakraborty, Raj K. Pandita, J Yordy, Deepti B. Ramnarain, Nobuo Horikoshi, Tej K. Pandita> ;Radiation Research. 2014 Jan 1
• 11 citations
  Wavelet Analysis in Current Cancer Genome Research: A Survey
  Tao Meng, Ahmed T. Soliman, Mei-Ling Shyu, Yimin Yang, Shu-Ching Chen, S. Sitharama Iyengar, J Yordy, Puneeth Iyengar> ;IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2013 Nov 1
• 12 citations
  A contour-guided deformable image registration algorithm for adaptive radiotherapy.
  Xuejun Gu, Bin Dong, Jing Wang, John Yordy, Loren Mell, Xun Jia, Steve B Jiang> ;Physics in Medicine and Biology. 2013 Mar 21
• 85 citations
  Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?
  Stephen G. Chun, Kevin S. Choe, Puneeth Iyengar, J Yordy, Robert Timmerman> ;Cancer Biology & Therapy. 2012 Sep 17
• 380 citations
  Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
  Lauren Averett Byers, Jing Wang, Monique B. Nilsson, Junya Fujimoto, Pierre Saintigny, John S. Yordy, Uma Giri, Michael Peyton, You Hong Fan, Lixia Diao, Fatemeh Masro...> ;Cancer Discovery. 2012 Sep 1
• 1 citations
  Development of the M. D. Anderson Cancer Center Gynecologic Applicators for the Treatment of Cervical Cancer: Historical Analysis
  J Yordy, Peter R. Almond, Luis Delclos> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Mar 15
• 215 citations
  TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
  Heath D. Skinner, Vlad C. Sandulache, Thomas J. Ow, Raymond E. Meyn, J Yordy, Beth M. Beadle, Alison L. Fitzgerald, Uma Giri, K. Kian Ang, Jeffrey N. Myers> ;Clinical Cancer Research. 2012 Jan 1
• 233 citations
  Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of...
  Christopher H. Crane, Gauri R. Varadhachary, John S. Yordy, Gregg A Staerkel, Milind Javle, Howard Safran, Waqar M. Haque, Bridgett D. Hobbs, Sunil Krishnan, Jason B. ...> ;Journal of Clinical Oncology. 2011 Aug 1
• 66 citations
  DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy
  Benjamin J. Moeller, John S. Yordy, Michelle D. Williams, Uma Giri, Uma Raju, David Molkentine, Lauren Averett Byers, John V. Heymach, Michael D. Story, J. Jack Lee, E...> ;Clinical Cancer Research. 2011 Apr 1
• 17 citations
  Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.
  Victoria J. Findlay, David P. Turner, John S. Yordy, Brent D. McCarragher, Marey R. Shriver, Gabor Szalai, Patricia M. Watson, Amanda C. LaRue, Omar Moussa, Dennis K. ...> ;Genes & Cancer. 2011 Feb 1
• Blasted Cell Line Names
  Jing Wang, Lauren Averett Byers, John S. Yordy, Wenbin Liu, Li Shen, Keith A. Baggerly, Uma Giri, Jeffrey N. Myers, K. Kian Ang, Michael D. Story, Luc Girard, John D. ...> ;Cancer Informatics. 2010 Oct 14
• 45 citations
  Prognostic and Functional Significance of Thromboxane Synthase Gene Overexpression in Invasive Bladder Cancer
  Omar Moussa, John S. Yordy, Hassan Abol-Enein, Debajyoti Sinha, Nabil K. Bissada, Perry V. Halushka, Mohamed A. Ghoneim, Dennis K. Watson> ;Cancer Research. 2005 Dec 15
• 36 citations
  SP100 inhibits ETS1 activity in primary endothelial cells.
  John S. Yordy, Omar Moussa, Huiping Pei, Damien Chaussabel, Runzhao Li, Dennis K. Watson> ;Oncogene. 2005 Jan 27
• Join now to see all